---
document_datetime: 2025-12-18 09:44:01
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/azacitidine-kabi-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: azacitidine-kabi-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 0.9243668
conversion_datetime: 2025-12-27 14:44:32.495494
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Azacitidine Kabi

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0002              | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process | 29/08/2024                          |                                             | SmPC                             |           |

<!-- image -->

<!-- image -->